# OnCo record nct03850795 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03850795/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03850795", "NCT03850795" ;
  schema:name "HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)"@en ;
  schema:description "A phase 3 trial of Deutenzalutamide run by Hinova Pharmaceuticals USA, Inc., terminated."@en ;
  schema:url <https://onco.cc/trials/nct03850795/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03850795> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:drugs <https://onco.cc/drugs/deutenzalutamide/> ;
  onco:companies <https://onco.cc/companies/hinova-pharmaceuticals/> .